Abstract:Background: Cytomegalovirus (CMV) infection has been associated with allograft rejection in solid organ transplantation. However, the immunologic mechanisms behind this observation have not been elucidated. One proposed mechanism is direct cross-reactivity of antiviral T-cells with allogeneic MHC/peptide complexes, a process termed heterologous immunity. Another model favours indirect stimulation of alloimmunity by CMV-induced proinflammatory cytokines and upregulation of MHC class II and adhesion molecules. Recently, we found that protection from CMV disease was correlated with high levels of CMV-immediate early-1 (IE-1) specific IFN-gamma-producing T-cell responses in heart and lung transplant recipients. The aim of this study was to define the relation of CMV-specific T-cell responses to acute rejection, donor-reactive memory T cells, and allograft function after kidney transplantation. Methods: To address this issue, IFN-gamma-producing T-cell responses following ex-vivo stimulation with pools of overlapping peptides representing the CMV pp65 and IE-1 proteins, as well as donor-reactive IFN-gamma-producing T-cells were determined at multiple time points before (pre-Tx) and during the first 6 months posttransplant (post-Tx) in 36 kidney transplant recipients using an enzyme linked immunoabsorbent spot assay (ELISPOT). Results: CMV-specific T cells were not exclusively detectable in CMV seropositive patients, as 3/12 seronegative patients had significant pre- and post-Tx pp65/IE-1-specific T-cell responses. In patients with detectable anti-CMV antibody or T-cell responses, no difference in CMV-specific T-cell frequencies was found between patients with versus without acute rejection. However, early (week 1, r=0.457, p=0.037) and average IE-1-specific T-cell responses (r=-0.415, p=0.032) during 6 months post-Tx showed a significant inverse correlation with average post-Tx donor-reactive T-cell responses. Furthermore, average post-Tx IE-1-specific T-cell responses correlated significantly with 6 and 12 months glomerular filtration rate (GFR). In contrast, pp65-specific T-cell responses did not correlate with donor-reactive T cells or graft function. Only 2/36 patients developed CMV disease, both showing very weak IE-1-specific T-cell responses during the whole monitoring period. Conclusion: No evidence for heterologous immunity could be found in patients with high levels of CMV-specific T cells. On the contrary, less alloreactivity and improved graft function were found in patients with strong IE-1-specific T-cell responses. These results emphasize the importance of immediate early antigens (IE) as targets for T-cell immunity to CMV. We hypothesize that IE-1-specific T cells might effectively suppress IE-1-induced indirect effects such as inflammation and upregulation of MHC class II and adhesion molecules.

The Incidence of Cytomegalovirus Infection and the Effects of Immune Inhibitor on Cytomegalovirus Infection in Renal Allograft Recipients

The Impact of Pretransplant Cytomegalovirus Infection on Acute Renal Allograft Rejection

Protective Immunity Transferred by Infusion of Cytomegalovirus-Specific CD8(+) T Cells Within Donor Grafts: Its Associations with Cytomegalovirus Reactivation Following Unmanipulated Allogeneic Hematopoietic Stem Cell Transplantation.

Improved Clinical Outcomes in Chinese Renal Allograft Recipients Receiving Lower Dose Immunosuppressants

Treatment Of Cytomegalovirus Infection After Renal Transplantation: Experience From A Single Center In China

Association of Cytomegalovirus Infection with Human Leukocyte Antigen Genotypes in Recipients after Allogeneic Liver Transplantation.

An Aggressive Systematic Strategy for Renal Allograft Recipients with Cytomegalovirus Pneumonia and Acute Respiratory Distress Syndrome

Prognostic Effect of Lymphocyte Subgroup CD4+ and CD8+ Cells in Peripheral Blood in Renal Transplant Patients With Cytomegalovirus Viremia

Early Immune Surveillance to Predict Cytomegalovirus Outcomes after Allogeneic Hematopoietic Stem Cell Transplantation.

Anti-Donor T-Cell Responses Are Not Necessarily Attenuated During Cytomegalovirus Infection in Kidney Transplant Recipients

Clinical Analysis of 2520 Renal Transplantations in One Center

A Primary Study on the Level of Human Cytomegalovirus Specmc CD8+ T Lymphocytes and IFN-γ Secretion Effect in Kidney Transplant Recipients

Allograft Rejection-Related Gene Expression in the Endothelial Cells of Renal Transplantation Recipients after Cytomegalovirus Infection

A clinical research of CMV antigenemia in the prevention of CMV diseases in renal transplant recipients

Prevention and Treatment of Cyomegalovirus Reinfection after Liver Transplantation

The clinical study on CMV pneumonia after kidney transplantation (analysis of 34 cases).

Preemptive therapy for prevention and treatment of cytomegalovirus disease after renal transplantation

Clinical Study of Cytomegalovirus Latent Infection in Allogeneic Peripheral Blood Stem Cell Transplantation

High levels of CMV-IE-1-specific memory T cells are associated with less alloimmunity and improved renal allograft function

[Cytomegalovirus Infection Monitoring in Patients with Long-Term Survival after Allogeneic Hematopoietic Stem Cell Transplantation].

DETECTION OF CYTOMEGALOVIRUS(CMV) IMMEDIATE EARLY ANTIGEN IN KIDNEY BIOPSIES AND TRANSPLANT NEPHRECTOMIES